# A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers

> **NCT00726427** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 32 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD1656
- **DRUG:** AZD1656

## Key facts

- **NCT ID:** NCT00726427
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2010-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00726427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00726427, "A Study to Evaluate Safety and Tolerability After Oral Dosing of AZD1656 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00726427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*